A glycolytic phenotype is associated with prostate cancer progression and aggressiveness: a role for monocarboxylate transporters as metabolic targets for therapy.
Pertega-Gomes N, Felisbino S, Massie CE, Vizcaino JR, Coelho R, Sandi C, Simoes-Sousa S, Jurmeister S, Ramos-Montoya A, Asim M, Tran M, Oliveira E, Lobo da Cunha A, Maximo V, Baltazar F, Neal DE, Fryer LG.
Pertega-Gomes N, et al. Among authors: vizcaino jr.
J Pathol. 2015 Aug;236(4):517-30. doi: 10.1002/path.4547.
J Pathol. 2015.
PMID: 25875424
Free PMC article.